Revelation Biosciences (FRA:56U0) FCF Yield % : -216.62 (As of May. 13, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Revelation Biosciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Revelation Biosciences's Trailing 12-Month Free Cash Flow is €-6.76 Mil, and Market Cap is €3.12 Mil. Therefore, Revelation Biosciences's FCF Yield % for today is -216.62%.

The historical rank and industry rank for Revelation Biosciences's FCF Yield % or its related term are showing as below:

FRA:56U0' s FCF Yield % Range Over the Past 10 Years
Min: -982.81 Med: 0 Max: 0
Current: -216.62

FRA:56U0's FCF Yield % is ranked worse than
92.15% of 1555 companies
in the Biotechnology industry
Industry Median: -14.28 vs FRA:56U0: -216.62

Revelation Biosciences's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Revelation Biosciences FCF Yield % Historical Data

The historical data trend for Revelation Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revelation Biosciences FCF Yield % Chart

Revelation Biosciences Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-285.92

-187.08

Revelation Biosciences Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial							-96.54	-101.97	-138.24	-163.52	-205.75

Competitive Comparison of Revelation Biosciences's FCF Yield %

For the Biotechnology subindustry, Revelation Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revelation Biosciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Revelation Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Revelation Biosciences's FCF Yield % falls into.

Revelation Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Revelation Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-6.681	/	3.57129
	=	-187.08%

Revelation Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.837	*	4	/	3.57129
	=	-205.75%

Revelation Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Revelation Biosciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Revelation Biosciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Revelation Biosciences (FRA:56U0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revelation Biosciences Inc (FRA:56U0) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

REVB:USA 56U1:Germany

Address

4660 La Jolla Village Drive, Suite 100, San Diego, CA, USA, 92122

Website

https://www.revbiosciences.com

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99.

Revelation Biosciences (FRA:56U0) Headlines

No Headlines